Evidence map›Paper›PMID 33920814›Full record

ArticlePathogens (Basel, Switzerland)2021

Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19.

Denise Morotti, Massimiliano Cadamuro, Elena Rigoli, Aurelio Sonzogni, Andrea Gianatti, Cristina Parolin, Luisa Patanè, David A Schwartz

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. The Innate Defense in the Zika-Infected Placenta.Pathogens (Basel, Switzerland) · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Denise MorottiDepartment of Pathology, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.ORCID 0000-0002-3309-8011
Massimiliano CadamuroDepartment of Molecular Medicine, University of Padova, 35122 Padova, Italy.ORCID 0000-0002-0899-7613
Elena RigoliDepartment of Pathology, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.
Aurelio SonzogniDepartment of Pathology, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.
Andrea GianattiDepartment of Pathology, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.
Cristina ParolinDepartment of Molecular Medicine, University of Padova, 35122 Padova, Italy.
Luisa PatanèObstetrics and Gynecology Department, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.
David A SchwartzDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-7486-8545
Ospedale Papa Giovanni XXIII · ITUniversity of Padua · ITAugusta University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A small number of neonates delivered to women with SARS-CoV-2 infection have been found to become infected through intrauterine transplacental transmission. These cases are associated with a group of unusual placental pathology abnormalities that include chronic histiocytic intervillositis, syncytiotrophoblast necrosis, and positivity of the syncytiotrophoblast for SARS-CoV-2 antigen or RNA. Hofbauer cells constitute a heterogeneous group of immunologically active macrophages that have been involved in transplacental infections that include such viral agents as Zika virus and human immunodeficiency virus. The role of Hofbauer cells in placental infection with SARS-CoV-2 and maternal-fetal transmission is unknown. This study uses molecular pathology techniques to evaluate the placenta from a neonate infected with SARS-CoV-2 via the transplacental route to determine whether Hofbauer cells have evidence of infection. We found that the placenta had chronic histiocytic intervillositis and syncytiotrophoblast necrosis, with the syncytiotrophoblast demonstrating intense positive staining for SARS-CoV-2. Immunohistochemistry using the macrophage marker CD163, SARS-CoV-2 nucleocapsid protein, and double staining for SARS-CoV-2 with RNAscope and anti-CD163 antibody, revealed that no demonstrable virus could be identified within Hofbauer cells, despite these cells closely approaching the basement membrane zone of the infected trophoblast. Unlike some other viruses, there was no evidence from this transmitting placenta for infection of Hofbauer cells with SARS-CoV-2.

Indexed as

ACE2coronaviruscoronavirus disease 2019COVID-19fetal infectionHofbauer cellintervillositismaternal-fetal transmissionplacentaSARS-CoV-2severe acute respiratory syndrome coronavirus 2TMPRSS2transplacental transmissionvillous macrophages

Identifiers

PMID33920814
PMCPMC8071113
OpenAlexW3153597799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.